Dimenhydrinate Injection

21 February 2008

Products Affected - Description

Dimenhydrinate 50 mg/mL injection
1 mL vial, package of 25 (NDC 63323-0366-01), APP Pharmaceuticals

Reason for the Shortage

APP Pharmaceuticals (formerly Abraxis) states the shortage was due to increased demand for product.

Estimated Resupply Dates

APP has product available.

Updated

February 21, 2008; January 22, 2008; Copyright 2008, University of Utah, Drug Information Service

Back to Drug Shortage Product Bulletins